Medication info
Zenvigsaeng 10 milligrams (Memantine Hydrochloride)

Zenvigsaeng 10 milligrams (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Poonglim Pharmaceutical Co., Ltd.
Appearance
Pale yellow to yellow oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202002221 · Approved 2020.03.31 · Insurance code 649002310

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This drug is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This drug may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1–7) Administer 5mg once daily for 7 days. Week 2 (Days 8–14) Administer 10mg once daily for 7 days. Week 3 (Days 15–21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose for patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-titration method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Ingredients

Manufacturer
Poonglim Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This drug is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This drug may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1–7) Administer 5mg once daily for 7 days. Week 2 (Days 8–14) Administer 10mg once daily for 7 days. Week 3 (Days 15–21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose for patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-titration method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Precautions

This medication should not be used in individuals allergic to its components. It is also advisable not to administer it to patients with severely impaired liver function or very compromised kidney function. Special care should be taken when using this medication in patients with epilepsy, those who have had seizures in the past, or those at risk of seizures. Co-administration with certain medications like amantadine, ketamine, and dextromethorphan may exacerbate side effects, so it is advisable not to take them together. Patients should carefully monitor their urine status when there are changes in urine acidity or dietary habits. Individuals with recent heart disease or uncontrolled hypertension should consult their physician about the use of this medication. During treatment, symptoms such as dizziness, headache, constipation, drowsiness, and increased blood pressure may occur; patients should inform their healthcare provider if symptoms are severe. There may be interactions with other medications, so patients must inform their healthcare provider about all medications they are taking, particularly when using anticoagulants or muscle relaxants. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and breastfeeding women are advised to discontinue nursing. The safety and efficacy of this medication have not been established in children and adolescents under 18 years of age, so its use is discouraged. In case of overdose, symptoms such as confusion, drowsiness, dizziness, hallucinations, and vomiting may occur, and immediate medical attention should be sought. This medication may affect the central nervous system, requiring caution when driving or operating machinery. It must be stored out of reach of children, and transferring it to another container should be avoided to maintain the quality and safety of the medication.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • drowsiness
  • confusion
  • hallucinations
Show 32 more
  • psychiatric reactions
  • dizziness
  • balance disorder
  • gait abnormality
  • seizures
  • heart failure
  • hypertension
  • venous thromboembolism/thrombosis
  • shortness of breath
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • headache
  • fatigue
  • tiredness
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • anxiety
  • aggression
  • hallucinations
  • gait disturbance
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • drowsiness
  • stupor
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a closed container to prevent air or moisture from entering. It is best to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow to yellow oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.